Pharming: promises and risks of biopharmaceuticals derived from genetically modified plants and animals

"Pharming" is a new branch of biotechnology where plants or animals are genetically engineered to produce pharmaceutical proteins. It is hoped that pharming may lead to new, better or cheaper drugs. However, questions remain with regard to the choice of plants or animals, environmental and pharmacological safety, the welfare of pharming animals, the legal regulation of pharming, societal concerns, and moral evaluation. To address these questions, the Europäische Akademie GmbH has conducted an interdisciplinary research project. Its participants here present the various angles of the topic, including recommendations for the further development and regulation of pharming. INDICE: Introduction.- The Technology of Pharming.- Risk Assessment of Plant- and Animal Pharming.- The Welfare of Pharming Animals.- Public Views and Attitudes to Pharming.- The Ethical Evaluation of Pharming.- The Role of Patents in the Development of Pharming.- Legal Problems of Pharming.- Conclusions and Recommendations.

• ISBN: 978-3-540-85792-1
• Editorial: Springer
• Encuadernacion: Cartoné
• Páginas: 370
• Fecha Publicación: 01/10/2008
• Nº Volúmenes: 1
• Idioma: Inglés